Skip to main content

. 1990 Nov;49(11):955. doi: 10.1136/ard.49.11.955-a

Antenatal administration of aminopropylidene diphosphonate.

D J Dunlop, M Soukop, H P McEwan

PMCID: PMC1004276 PMID: 2256749

955

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cantwell B. M., Harris A. L. Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer. Br Med J (Clin Res Ed) 1987 Feb 21;294(6570):467–469. doi: 10.1136/bmj.294.6570.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
Ralston S. H., Gardner M. D., Dryburgh F. J., Jenkins A. S., Cowan R. A., Boyle I. T. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia. Lancet. 1985 Oct 26;2(8461):907–910. doi: 10.1016/s0140-6736(85)90848-7. [DOI] [PubMed] [Google Scholar]
Sleeboom H. P., Bijvoet O. L., van Oosterom A. T., Gleed J. H., O'Riordan J. L. Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia. Lancet. 1983 Jul 30;2(8344):239–243. doi: 10.1016/s0140-6736(83)90231-3. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES